"十四五"期间，科技城累计开展"揭榜挂帅"等关键技术攻关项目298项，16项成果获国家科学技术奖，169项成果 获省科学技术奖 文 |《瞭望》新闻周刊记者 李松 新松机器人实现高端应用里程碑式突破，东软直线加速器核心技术打破国际垄断，3409家科技型中小企业扎根生 长……在沈阳浑南科技城，这样的科创图景正不断铺展。 近年来，辽宁省锚定破解产业升级瓶颈、激活区域创新动能的目标，统筹高校、科研院所、金融机构等要素资 源，推进创新链、产业链、资金链、人才链深度融合，全力打造浑南科技城这一区域科技创新高地。 如今，这座以生态沃土涵养"科创雨林"的科技新城，正成为辽宁产业转型升级的"加速器"、创新驱动发展的"强引 擎"，为老工业基地焕发新生机注入澎湃动能。 自2022年浑南科技城核心区基建全面启动，即深耕生产、生活、生态"三生融合"理念，全力打造"宜创、宜业、宜 居"的科技创新生态，如今初步建成承载能力强、专业水平高、服务功能全的创新支撑平台。 生产层面，浑南科技城围绕"5+1"主导产业，形成"一谷七园"产业布局，推动重点细分领域实现较快增速，助力从 实验室到产业园的转化路径更畅通。 生活层面，建设和储备公寓超5000 ...

河南省2025年医疗器械招标项目总计5061个，招标预算总金额约95.89亿元。相较于2024年，2025年招 标规模有所增加，其中招标项目从4572个增至5061个，增幅超10%，招标预算总金额从71.12亿元增至 94.98亿元，增幅超30%。（获取详细数据，请添加立方招采通客服微信：SK_lifangzct） 【大河财立方 记者 唐卫东】据立方招采通数据统计，2025年，河南省共有超过600家医疗机构及相关单 位发布招标公告，医疗器械招标及中标信息总计超8000条，医用耗材招标及中标信息总计超2000条。其 中，医疗器械单个项目超过1000万元的，招标项目201个，中标项目145个，郑州市在数量及金额方面都 远超其他城市。 孟州市第一人民医院新建项目医疗设备（第一批）及部分设备购置项目预算金额高达1.55亿元，是今年 预算金额最高的项目；新乡医学院第一附属医院3.0T磁共振购置项目中标金额为8256.5万元，在单个项 目中标金额中排在第1位；此外，还有多个大额项目进行分批采购。医用耗材招标呈季度梯度上升态 势，郑州、新乡、许昌三城领跑，检验类、影像类耗材成为采购热点。 医疗器械招标项目超5000个，郑大 ...

推动优质医疗资源下沉基层 羊城晚报全媒体记者 徐炜伦 2月10日，中山大学肿瘤医学科学中心（天河院区）项目主体结构全面封顶，进入装饰装修、设备安装等下一步建设阶段，致力打造国内专科布局最全、规 模最大、水平最高的肿瘤中心。以该项目为代表，在新春到来之前，广州市天河区一批"百千万工程"医疗健康项目如期达到重要工期节点，标志着天河区医 疗健康事业"量质齐升、全域均衡"的发展新格局正加速形成。 "毫米级精度施工"为项目建设保驾护航 据悉，中山大学肿瘤医学科学中心（天河院区）项目位于天河区龙洞片区，总建筑面积约29.9万平方米，建设内容包括门诊、急诊、医技、住院、行政后 勤、保障系统、科研实验等，建成后，将成为集"医、教、研、防"于一体的世界级肿瘤医学科学中心。该项目拥有5间重离子舱、10台直线加速器等71台先 进大型医用设备，形成国内顶尖的肿瘤诊断治疗集群，预计日门诊量约6000人次，建设床位约1100张。 作为天河区落实"百千万工程"、推动城乡区域协调发展的重要抓手，它直接响应了补齐公共服务短板的号召。项目配套建设社区卫生服务中心，旨在将国家 级肿瘤防治"国家队"的资源和能力下沉至龙洞街道基层，构筑起从尖端科研到 ...

证券日报网讯2月6日，新华医疗（600587）在互动平台回答投资者提问时表示，直线加速器、大孔径 CT、后装治疗机均为公司放疗核心优势产品，公司将依规参与符合资质的医疗设备招标项目，积极拓 展市场，为公司创造更多价值。 ...

（编辑 王雪儿） 证券日报网讯 1月30日，新华医疗在互动平台回答投资者提问时表示，公司在安哥拉的相关订单金额正 在稳步增长，直线加速器等高端设备产品正在与安哥拉当地医疗机构保持深度沟通，积极推进市场开发 工作。 ...

Group 1: Event Overview - The "2025 Financial Annual Conference" was successfully held in Beijing, focusing on "crossing cycles and resilient growth" with participation from regulatory bodies, industry associations, and over 200 listed companies [1] - The "Golden Intelligence Award" was announced, recognizing over 140 companies, including Haier Smart Home and Dongpeng Beverage, as models of high-quality development from more than 8,000 A-share, Hong Kong, and Chinese concept stocks [1] Group 2: Industry Insights - Maysun Medical, a leader in high-end tumor radiotherapy equipment, is positioned as a global high-tech enterprise with a comprehensive layout in the U.S. and China, focusing on proton therapy and linear accelerators [3] - The Chinese medical device market is projected to reach 1.22 trillion yuan by 2025, making it the second-largest globally, with expectations to grow to 1.81 trillion yuan by 2035 [3] Group 3: Challenges and Opportunities - Despite the growth, multinational companies still dominate the high-end product sector, with no Chinese firms in the top 20 global medical device companies [4] - The "14th Five-Year Plan" period is seen as a golden opportunity for Chinese high-end medical equipment, driven by supportive policies and a large domestic market [4] - The industry faces challenges such as intensified competition and significant funding pressures, with a need for substantial investment in R&D and market promotion [6][5] Group 4: Future Outlook - The combination of the "14th Five-Year Plan," domestic market demand, and enhanced internationalization capabilities is expected to help the Chinese medical device industry overcome development bottlenecks and become a global production base [7]

Core Viewpoint - The article highlights the significant growth of United Imaging Healthcare in the high-end imaging equipment sector, indicating a transition from domestic competition to becoming a global benchmark in the industry [2][12]. Financial Performance - In Q3 2025, the company achieved revenue of approximately 2.843 billion yuan, representing a year-on-year increase of about 75.41% [8]. - For the first three quarters of 2025, total revenue reached approximately 8.859 billion yuan, with a year-on-year growth of about 27.39% [8]. - The net profit attributable to shareholders for the first three quarters was approximately 1.120 billion yuan, reflecting a year-on-year increase of about 66.91% [8]. - The net profit after deducting non-recurring gains and losses was approximately 1.053 billion yuan, showing a remarkable year-on-year growth of about 126.94% [8]. Product and Business Drivers - The company’s main products include MR, CT, PET/CT, XR, and linear accelerators, with recent launches of several globally innovative or domestically first devices, such as silicon carbide MRI and long-axis PET/CT [5]. - The acceleration of high-end equipment deployment has significantly contributed to the company's revenue growth [5]. International Expansion - During the reporting period, the company made significant breakthroughs in key markets such as North America, Europe, Southeast Asia, and Latin America, with products now covering over 90 countries and regions [6]. - The company serves more than 15,700 institutions globally, enhancing its international competitive capability [6]. Market Structure Improvement - The company has seen an increase in market share in several high-end imaging equipment segments, indicating a shift from mid-range to high-end and solution-oriented devices [9]. Strategic Perspective - United Imaging Healthcare is currently in a critical strategic enhancement phase, transitioning from merely product delivery to becoming a comprehensive medical imaging service provider [11]. - This strategic shift aims to secure a deeper position within the global healthcare system [11]. Conclusion - Overall, the Q3 report demonstrates strong growth momentum for United Imaging Healthcare, with significant revenue increases, improved profitability, and accelerated deployment of high-end products [12]. - Future focus areas include sustaining growth momentum, particularly in high-end equipment delivery, overseas service network establishment, and deep collaborations with hospitals [12].

Group 1: Project Highlights - The article highlights several procurement projects including engineering construction, medical equipment, business services, and financial services [1][2] - Key projects to focus on include the sound equipment procurement for the Henan Art Center and the medical equipment purchase for the Dan County Traditional Chinese Medicine Hospital [1] Group 2: Henan Art Center Sound Equipment Procurement - The procurement method for the Henan Art Center sound equipment project is open bidding with a budget of approximately 24.87 million yuan [2] - The project involves upgrading the sound amplification system, tuning system, and microphone system for the main theater, small theater, and concert hall [2] - The deadline for bid submission is June 3, 2025, at 09:00 [2] Group 3: Dan County Traditional Chinese Medicine Hospital Equipment Purchase - The Dan County Traditional Chinese Medicine Hospital plans to purchase 61 sets of medical equipment with a budget of about 111 million yuan [2] - The equipment includes traditional Chinese rehabilitation therapy devices, linear accelerators, CT scanners, color Dopplers, treatment devices, monitors, and ventilators, along with a smart hospital network system [2] - The expected procurement time is June 2025 [2] Group 4: Other Notable Projects - The Zhengzhou Natural Resources and Planning Bureau is conducting a detailed planning framework agreement procurement project with a budget of 25 million yuan [3] - The Henan Children's Hospital is seeking medical liability insurance through an open bidding process [3] - The New Xiang Vocational Technical College is initiating a construction project for a virtual simulation training base [3]

以下文章来源于动脉网 ，作者赵泓维 作者 | 赵泓维 来源 | 动脉网 （ID：vcbeat） 医疗设备厂商的日子近来不太好过。 国信证券的一份调研报告显示：2024年上半年全国医疗设备中标总金额仅为520亿元， 同比降幅高达35%。 动脉网 . 动脉网（www.vbdata.cn）聚焦于技术驱动下生命健康领域产业创新和变革的报道与研究。 设备销量放缓。 其中，磁共振、CT、超声、内窥镜、监护设备的形势尤为严峻，以上品类中标金额分别 为65亿、65亿、60亿、45亿和10亿；对应降幅-40%、-40%、-40%、-50% 和-50%，每一类设备的销量都几近腰斩。 2023Q1-2024Q2医疗设备重要品类中标金额情况（单位：亿元；数据来源：国信证 券） 宏观下的萧条给予了每一家企业同等体验。无论国产龙头迈瑞联影，还是跨国巨擘 GPS，这半年间交出的答卷都不尽如人意。 如今凛冬已至，医学设备的转机还有多远？ 设备销量放缓，企业到底承了多少压？ 医疗设备市场急速缩紧背后，一个最为明显的原因是2023年年中开启的医药反腐风暴。 作为此次行动的重灾区，医疗器械相关的违法操作层出不穷。很多医院管理者通过虚报 费用、收受 ...